FARALLON CAPITAL MANAGEMENT LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 165 filers reported holding CARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,799,873
-40.6%
1,666,5910.0%0.01%
-41.7%
Q2 2023$4,716,453
-51.9%
1,666,591
-16.5%
0.02%
-55.6%
Q1 2023$9,797,267
-56.0%
1,995,370
-3.8%
0.05%
-59.4%
Q4 2022$22,276,908
-4.8%
2,074,200
-17.0%
0.13%
+3.1%
Q3 2022$23,400,000
+2.5%
2,500,0000.0%0.13%
+3.2%
Q2 2022$22,825,000
-24.9%
2,500,0000.0%0.12%
-15.0%
Q1 2022$30,375,000
+24.7%
2,500,000
+25.0%
0.15%
+20.5%
Q4 2021$24,360,000
-21.2%
2,000,0000.0%0.12%
-15.3%
Q3 2021$30,900,000
+8.3%
2,000,0000.0%0.14%
+23.1%
Q2 2021$28,540,000
-46.7%
2,000,000
-18.9%
0.12%
-56.0%
Q1 2021$53,515,000
+43.5%
2,465,0000.0%0.27%
+18.8%
Q4 2020$37,295,000
+30.3%
2,465,000
+9.6%
0.22%
+13.1%
Q3 2020$28,631,000
-27.2%
2,250,000
-2.2%
0.20%
-37.1%
Q2 2020$39,330,000
+29.4%
2,300,0000.0%0.32%
+20.7%
Q1 2020$30,383,000
-18.0%
2,300,0000.0%0.26%
+4.4%
Q4 2019$37,053,000
-5.7%
2,300,000
+7.0%
0.25%
-15.8%
Q3 2019$39,302,000
+92.1%
2,150,000
+126.0%
0.30%
+123.3%
Q2 2019$20,454,000951,3260.13%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders